BICYCLE THERAPEUTICS PLC-ADR
BCYCNASDAQ🏆 #3371 by market capEarnings Mar 15 · PostUS Equity
$3.82▼ $0.06 (−1.55%)
🌙 After hours$3.82▲ 0.00%Regular close · extended-hours price shownTrack BCYC
Get earnings, price moves & breaking news on Telegram
24h▼ 1.6%
7d▲ 7.6%
14d▲ 10.7%
30d▲ 3.7%
ytd▼ 45.8%
1y▼ 56.2%
🏦Market Cap
$267M
Small Cap
📈Revenue Growth (YoY)
217.4%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
4.4x
Fair
Otter Score
—
Insufficient data
BICYCLE THERAPEUTICS PLC-ADR
BCYCAnalyst Ratings
Price
$3.82
Total
21
Raised
1
Lowered
0
Avg PT
$10.00
H / L
$10 / $10
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Needham | Reiterated | Buy | 2026-07-30 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-04-08 | $12.00 | +214.10% |
Oppenheimer | Reiterated | Outperform | 2026-03-18 | $48.00 | +1156.50% |
RBC Capital | Reiterated | Sector Perform | 2026-03-18 | $11.00 | +188.00% |
Citizens | Reiterated | Market Outperform | 2026-03-18 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-08-12 | $12.00 | +214.10% |
B. Riley Securities | Reiterated | Neutral | 2025-05-02 | — | — |
Barclays | Reiterated | Overweight | 2025-05-01 | — | — |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-26 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-02-26 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2025-01-22 | — | — |
Canaccord Genuity | Reiterated | Buy | 2024-02-21 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2023-11-08 | — | — |
EF Hutton | Reiterated | Buy | 2023-04-19 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-08-31 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-08-22 | — | — |
Piper Sandler | Reiterated | Overweight | 2022-05-23 | $76.00 | +1889.50% |
Roth Capital | Reiterated | Buy | 2019-11-14 | $65.00 | +1601.60% |
Goldman Sachs | Upgraded | Neutral → Buy | 2019-09-11 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-06-17 | — | — |
Jefferies | Reiterated | Buy | 2019-06-17 | $10.00 | +161.80% |
Institution
Needham
Reiterated · Buy · 2026-07-30
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-04-08
$12.00
+214.10%
Oppenheimer
Reiterated · Outperform · 2026-03-18
$48.00
+1156.50%
RBC Capital
Reiterated · Sector Perform · 2026-03-18
$11.00
+188.00%
Citizens
Reiterated · Market Outperform · 2026-03-18
—
—
JMP Securities
Reiterated · Market Outperform · 2025-08-12
$12.00
+214.10%
B. Riley Securities
Reiterated · Neutral · 2025-05-02
—
—
Barclays
Reiterated · Overweight · 2025-05-01
—
—
Citizens Capital Markets
Reiterated · Market Outperform · 2025-02-26
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-02-26
—
—
Stephens & Co.
Reiterated · Equal Weight · 2025-01-22
—
—
Canaccord Genuity
Reiterated · Buy · 2024-02-21
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2023-11-08
—
—
EF Hutton
Reiterated · Buy · 2023-04-19
—
—
Cowen & Co.
Reiterated · Outperform · 2022-08-31
—
—
SVB Leerink
Reiterated · Outperform · 2022-08-22
—
—
Piper Sandler
Reiterated · Overweight · 2022-05-23
$76.00
+1889.50%
Roth Capital
Reiterated · Buy · 2019-11-14
$65.00
+1601.60%
Goldman Sachs
Upgraded · Neutral → Buy · 2019-09-11
—
—
Piper Jaffray
Reiterated · Overweight · 2019-06-17
—
—
Jefferies
Reiterated · Buy · 2019-06-17
$10.00
+161.80%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space